Age-specific HPV prevalence among 116,052 women in Australia’s renewed cervical screening program: A new tool for monitoring vaccine impact

• HPV based cervical screening can generate precise HPV prevalence estimates. • Among 116,118 samples from Australian women aged 25–74, 9.2% had oncogenic HPV. • HPV16/18 was stable with age, unlike other oncogenic types, due to HPV vaccination.